Cunningham Jonathan W, Nathan Ashwin S, Rhodes Jonathan, Shafer Keri, Landzberg Michael J, Opotowsky Alexander R
Department of Medicine, Brigham and Women's Hospital, Boston, MA.
Department of Cardiology, Hospital of the University of Pennsylvania, Philadelphia, PA.
Am Heart J. 2017 Jul;189:184-192. doi: 10.1016/j.ahj.2017.04.009. Epub 2017 Apr 27.
Peak oxygen consumption (pVO) measured by cardiopulmonary exercise test (CPET) predicts mortality in adults with a Fontan circulation. The purpose of this study was to assess the additive prognostic value of change in pVO over time.
We analyzed a cohort of adults (≥18 years old) with a Fontan circulation who underwent at least 2 maximal CPETs separated by 6-30 months at Boston Children's Hospital between 2000 and 2015. Survival analysis was performed to determine whether changes in CPET variables, including pVO between consecutive tests, were associated with subsequent clinical events. The primary outcome was transplant-free survival.
The study included 130 patients with 287 CPET test pairs. Average age was 26.6±9.5 years. Baseline pVO averaged 22.0±5.7 mL/kg/min or 60.9%±13.7% predicted. In the cohort overall, there was no change in mean pVO between sequential CPETs. Eleven patients died and 2 underwent transplant. On average, pVO declined for patients who subsequently died or underwent transplant but remained stable among those who did not (-9.8%±14.6% vs 0.0±13.0%, P<.01). Those with a decline in pVO between CPETs were at greater risk of death or transplantation (per 10% decrease in pVO: HR=2.0, 95% CI 1.2-3.1, P=.004). Change in pVO remained a significant predictor of death or transplant after adjusting for pVO at first CPET (per 10% decline in pVO: HR=2.5, 95% CI 1.5-4.2, P<.001).
A decline in pVO between consecutive CPETs predicts increased risk for death or transplant in adults with a Fontan circulation independent of baseline pVO. These results support the additive clinical value of serial CPET in this population.
通过心肺运动试验(CPET)测量的峰值耗氧量(pVO)可预测接受Fontan循环手术的成年人的死亡率。本研究的目的是评估pVO随时间变化的附加预后价值。
我们分析了一组接受Fontan循环手术的成年人(≥18岁),他们于2000年至2015年期间在波士顿儿童医院接受了至少两次间隔6 - 30个月的最大CPET检查。进行生存分析以确定CPET变量的变化,包括连续两次检查之间的pVO,是否与随后的临床事件相关。主要结局是无移植生存。
该研究纳入了130例患者,共进行了287对CPET检查。平均年龄为26.6±9.5岁。基线pVO平均为22.0±5.7 mL/kg/min或预测值的60.9%±13.7%。在整个队列中,连续CPET检查之间的平均pVO没有变化。11例患者死亡,2例接受了移植。平均而言,随后死亡或接受移植的患者pVO下降,但未死亡或接受移植的患者pVO保持稳定(-9.8%±14.6% vs 0.0±13.0%,P<.01)。CPET检查之间pVO下降的患者死亡或移植风险更高(pVO每降低10%:HR = 2.0,95% CI 1.2 - 3.1,P =.004)。在对首次CPET检查时的pVO进行调整后,pVO的变化仍然是死亡或移植的显著预测因素(pVO每下降10%:HR = 2.5,95% CI 1.5 - 4.2,P<.001)。
连续CPET检查之间pVO的下降预示着接受Fontan循环手术的成年人死亡或移植风险增加,且独立于基线pVO。这些结果支持了系列CPET在该人群中的附加临床价值。